nstitutive p38alpha mitogen-activated protein kinase activity[J].J Biol Chem,2000,275(16):12 266-12 272.
[3] Han J,Lee JD,Bibbs L,et al.A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells[J].Science,1994,265(5 173):808-811.
[4] Kyriakis JM,Avruch J.Sounding the alarm:protein kinase cascades activated by stress and inflammation[J].J Biol Chem,1996,271(40):24 313-24 316 .
[5] Yan feifei.Overexpression of p38MAPK protein in breast cancer and the regulation of preoperative chemotherapy[J].China J general surgery,2002,17(6):343-345.
[6] Zhang XQ,Pang ZJ,Cheng SJ,et al.p38MAPK inhibitor SB203580 in inhibition of in vitro invision of human choriocarcinoma JAR cells[J].Practical tumor journal,2003,18(2):95-97.
[7] Mao H,Yuan AM,Zhao MF,et al.The effect of signal passway of mitogen activated protein kinase on hepatocellular carcinoma metastasis induced by VEGF[J].Chinese digestive journal,2002,20(1):14-16.
[8] Loda M.Increased Proteasome-dependent degradation of the cyclin-dependent kinase inhibitor 27 in aggressive colorectal carcinomas[J].Nature medicine,1997,3:231-234.
[9] Yao J,Eu KW,Seow-Choen F,et al.Down-regulation of p27 is a significant predictor of poor overall survival and may facilitate metastasis in colorectal carcinomas[J].Int J Carcer,2000,89(3):213-216.
[10] Fredersdorf S,Burns J,Milne AM,et al.High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers[J].Proc Natl Acad Sci U S A,1997,94(12):6 380-6 385.
[11] Spirin KS,Simpson JF,Takeuchi S,et al.p27/Kip1 mutation found in breast cancer[J].Cancer Res,1996,56(10):2 400-2 404.
[12] Tomoda K,Kubota Y,Kato J.Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1[J].Nature,1999,398(6 723):160-165.
仁和医学论文网专业提供代写代发医学论文服务,并提供大量论文资料,
上一页 [1] [2] [3] [4] [5] 下一页